Sarissa Capital Management

Sarissa Capital Management as of Sept. 30, 2015

Portfolio Holdings for Sarissa Capital Management

Sarissa Capital Management holds 18 positions in its portfolio as reported in the September 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Abbvie (ABBV) 21.2 $86M 1.6M 54.41
Ariad Pharmaceuticals 18.5 $75M 13M 5.84
Medicines Company 14.7 $60M 1.6M 37.96
Quest Diagnostics Incorporated (DGX) 8.7 $35M 575k 61.47
Aegerion Pharmaceuticals 8.6 $35M 2.6M 13.60
Intra Cellular Therapies (ITCI) 6.3 $26M 640k 40.04
Merck & Co (MRK) 4.9 $20M 400k 49.39
Pacira Pharmaceuticals (PCRX) 3.9 $16M 380k 41.10
Amgen (AMGN) 3.1 $12M 90k 138.32
Esperion Therapeutics (ESPR) 2.6 $11M 448k 23.59
Apricus Bioscience 2.4 $9.5M 6.5M 1.46
Repros Therapeutics 2.1 $8.4M 1.1M 7.43
Vivus 1.0 $4.2M 2.6M 1.64
Kindred Biosciences 0.9 $3.6M 689k 5.20
AVEO Pharmaceuticals 0.7 $2.8M 2.3M 1.21
Biosante Pharmaceuticals (ANIP) 0.3 $1.2M 31k 39.52
Catalyst Biosciences 0.1 $419k 90k 4.66
Eleven Biotherapeutics 0.0 $99k 41k 2.40